Company: APXIF
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026339
Chunk: 296

Company: APx Acquisition Corp. I
Filing Date: 2025-03-31
Form: F-4/A
Chunk 296
---
ctioned Person or Restricted Person; (ii) involving any Sanctioned Jurisdiction; or (iii) otherwise in violation of Anti -MoneyLaundering Laws, Sanctions, or International Trade Laws; •permit Parent or any holder of Company Shares to transfer, sell, lease, license, mortgage, pledge, surrender, encumber, divest, cancel, abandon or allow to lapse or expire or otherwise dispose of any Company Shares, or recognize any such transfer, sale, lease, license, mortgage, pledge, surrender, encumbrances, divestment, cancellation, abandonment or other disposition of Company Shares and any such attempted action shall be null and void and Company will not inscribe any such transfer (of any kind as contemplated in this provision) in the shareholder register of Company; •in the case of Merger Sub only, conduct any business activities other than those solely related to the consummation of the Transactions; or •enter into any agreement to do any action prohibited under these covenants. Covenants of the Company and Merger Sub The Business Combination Agreement also contains certain other covenants and agreements among the Company and Merger Sub (subject to the terms and conditions contained therein) which include: •in the event that any litigation related to the Business Combination Agreement, any other Transaction Document or the Transaction is brought, or, to the knowledge of the Company or Merger Sub, threatened in writing, against the Company any of its Subsidiaries or Merger Sub, or any of its Subsidiaries, or the board of directors of the Company, any of its Subsidiaries, or Merger Sub, or any of its Subsidiaries, by any shareholders of the Company prior to Closing, the Company or Merger Sub, as applicable, shall promptly after becoming aware of such litigation notify SPAC of such litigation and keep SPAC reasonably informed with respect to the status thereof; and •the Company and Merger Sub shall provide SPAC the opportunity to participate in (at SPAC’s own cost and expense and subject to a customary joint defense agreement), but not control, the defense of any such litigation, shall consider in good faith SPAC’s suggestions with respect to such litigation and shall not settle any such litigation without prior written consent of SPAC, such consent not to be unreasonably withheld, conditioned, delayed or denied. •the Company shall cause the consummation of the Restructuring, and the Company shall exercise its reasonable best efforts to take, or